Non-Small Cell Lung Cancer: Genomic Testing & Current Treatment Trends

Listen Now

Topics Covered

• Non-Small Cell Lung Cancer Overview, in the Context of COVID-19
• Definition of Genomics & Genomic Testing
• The Difference between Genomics & Genetics
• The Role of Genomic Testing in the Treatment of Non-Small Cell Lung Cancer, in the Context of COVID-19
• Specific Examples of How Genomic Testing May Inform Treatment Decisions
• Precision Medicine & Non-Small Cell Lung Cancer
• Current Research in Genomics & Non-Small Cell Lung Cancer
• Liquid Biopsies
• The Role of the Pathologist
• Reviewing Your Pathology Report with Your Pathologist & Health Care Team
• Key Questions to Ask Your Health Care Team about Genomic Testing & Its Benefits for Your Treatment Choices
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions
• Follow-Up Care & OpenNotes Discussions
• Questions for Our Panel of Experts

Our Panel of Experts

Michael D. Offin, MD

Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center

Joshua K. Sabari, MD

Attending Physician, Thoracic Medical Oncology, Assistant Professor of Medicine, NYU Langone Health, Perlmutter Cancer Center

W. Victoria Lai, MD

Assistant Attending Physician, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center

Sarah E. Kerr, MD

Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; Molecular Diagnostic Lead Pathologist for Next Generation Sequencing Development and Practice, Allina Health Laboratory (A Part of Abbott Northwestern Hospital)

Amy C. Moore, PhD

Vice President, Global Engagement and Patient Partnerships, LUNGevity Foundation^®

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on November 09, 2021.